SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5.46 |
| Enterprise Value ($M) | -6.73 |
| Book Value ($M) | 25.04 |
| Book Value / Share | 12.52 |
| Price / Book | 0.22 |
| NCAV ($M) | 20.96 |
| NCAV / Share | 10.48 |
| Price / NCAV | 0.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.17 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | -0.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.57 |
| Current Ratio | 5.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 25.98 |
| Assets | 30.06 |
| Liabilities | 5.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Policy Basic | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 0.00 | -100.00 | |
| 13G | L1 Capital Global Opportunities Master Fund, Ltd. | 5.30 | ||
| 13G | Altium Capital Management LP | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 24,334 | 129,652 | 18.77 | |
| 82,603 | 476,812 | 17.32 | |
| 535,272 | 1,488,746 | 35.95 | |
| 160,112 | 666,799 | 24.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RZLT – Rezolute, Inc. | SABS – SAB Biotherapeutics, Inc. |
| SAVA – Cassava Sciences, Inc. | SCLX – Scilex Holding Company |
| SGMO – Sangamo Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io